Patient baseline characteristics in the PROMETCO study: a real-world, prospective longitudinal cohort on the continuum of care of metastatic colorectal cancer

PROMETCO study: Metastatic colorectal cancer (mCRC) treatment patterns of the first 531 enrolled patients